FIBROGEN INC overview

FIBROGEN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against FibroGen, Inc. - FGEN PR Newswire NEW ORLEANS, June 10, 2021 NEW ORLEANS , June 10, 2021 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana , Charles C. Foti, Jr. , remind investors that they have only until June 11, 2021 to file lead plaintiff...

The Law Offices of Frank R. Cruz reminds investors of the upcoming June 11, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired FibroGen Inc. (“FibroGen” or the “Company”) (NASDAQ: FGEN ) securities between November 8, 2019 and April 6, 2021 , inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. FibroGen is a biopharmaceutical company that develops...

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until June 11, 2021 to file lead plaintiff applications in securities class action lawsuits against FibroGen, Inc. (NasdaqGS: FGEN), if they purchased the Company’s securities and/or sold put options between October 18, 2017 and April 6, 2021, inclusive (the “Class Period”). These actions are pending in the United States District Court for the...

Deadline Alert: Kessler Topaz Meltzer & Check, LLP Alerts Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Against FibroGen, Inc. PR Newswire RADNOR, Pa., June 7, 2021 RADNOR, Pa. , June 7, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against FibroGen, Inc. (NASDAQ: FGEN) ("FibroGen") on behalf of those who purchased or acquired FibroGen securities and/or sold put...

Class Action Lawsuit Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against FibroGen, Inc. PR Newswire RADNOR, Pa., June 1, 2021 RADNOR, Pa. , June 1, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against FibroGen, Inc. (NASDAQ: FGEN) ("FibroGen") on behalf of those who purchased or acquired FibroGen securities and/or sold put...

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against FibroGen Inc. (FGEN) Shareholders with losses exceeding $100,000 are encouraged to contact the firm PR Newswire LOS ANGELES, May 28, 2021 LOS ANGELES , May 28, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 11, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired...

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of FibroGen Inc. (FGEN) Investors Shareholders with $100,000 losses or more are encouraged to contact the firm PR Newswire LOS ANGELES, May 20, 2021 LOS ANGELES , May 20, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired FibroGen Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN)...

Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, announces the filing of a class action lawsuit against FibroGen, Inc. (“FibroGen” or the “Company”) (NASDAQ: FGEN) and certain of its officers, alleging violations of federal securities laws. If you purchased FibroGen securities between November 8, 2019 through April 6, 2021 (the “Class Period”), and have suffered a loss, you are encouraged to contact attorney...

FGEN INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fibrogen Inc. PR Newswire NEW YORK, May 17, 2021 NEW YORK , May 17, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...

FGEN ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against FibroGen, Inc. - Expanded Class Period PR Newswire RADNOR, Pa., May 16, 2021 RADNOR, Pa. , May 16, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that securities fraud class action lawsuits have been filed in the United States District Court for the Northern District of California against FibroGen, Inc. (NASDAQ: FGEN) ("FibroGen") on behalf of...

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against FibroGen Inc. (FGEN) Investors with losses exceeding $100,000 are encouraged to contact the firm PR Newswire BENSALEM, Pa., May 11, 2021 BENSALEM, Pa. , May 11, 2021 /PRNewswire/ -- Law Offices of Howard G. Smith reminds investors of the upcoming June 11, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or...

HAGENS BERMAN Alerts FibroGen (FGEN) Investors to EXPANDED FRAUDULENT PERIOD in Securities Fraud Action: Investors Should Secure Counsel PR Newswire SAN FRANCISCO, May 11, 2021 SAN FRANCISCO , May 11, 2021 /PRNewswire/ -- Hagens Berman urges FibroGen, Inc. (NASDAQ: FGEN) investors with significant losses to submit your losses now . Class Period: Oct. 18, 2017 – Apr. 6, 2021 Lead Plaintiff Deadline: June 11, 2021 Visit: www.hbsslaw.com/cases/FGEN Contact An Attorney Now: FGEN@hbsslaw.com...

Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of a Securities Class Action Lawsuit Against FibroGen, Inc. PR Newswire NEW YORK, May 6, 2021 NEW YORK , May 6, 2021 /PRNewswire/ -- Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") filed a class action lawsuit for violations of the federal securities laws in the U.S. District Court for the Northern District of California against FibroGen, Inc. ("FibroGen" or "the...

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against FibroGen Inc. (FGEN) Shareholders with losses exceeding $100,000 are encouraged to contact the firm PR Newswire LOS ANGELES, May 5, 2021 LOS ANGELES , May 5, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 11, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired FibroGen...

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities and/or sold put options of FibroGen, Inc. (“FibroGen” or the “Company”) (NASDAQ: FGEN) between November 8, 2019 and April 6, 2021, inclusive (the “Class Period”). If you purchased or otherwise acquired FibroGen securities and/or sold FibroGen put options during the Class Period, you may move the Court...